| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |